Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Ruxolitinib cream may help treat severe hair loss in children.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Co-trimoxazole may help treat autoimmune diseases.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Biosimilars lower costs but don't significantly improve access.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Ustekinumab helped three kids with alopecia areata regrow hair.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Rituximab may cause skin issues, but baricitinib can help improve them.